BIOLASE Inc. (BIOL): Market Cap jumped to 24.95M


BIOLASE Inc. (NASDAQ:BIOL) changes shares on Thursday trading session, with a change of -4.20% or -$0.02 shares. The trading starts at $0.507 and closed at $0.52 throughout the day. The trading session low price was $0.4866 and day high was $0.512 on Thursday, June 25. After the session, the Healthcare sector daily volume shifted to 2.67 million while its average volume is 5.53M. In other hand, the BIOL market cap reached to $24.95M. While, its current target price is $0.50 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 0.69% and up 1.27% for month. Its quarterly performance was -6.60% below, while its half year performance is down -0.04%. BIOL yearly performance stood at negative -66.10% and fall -10.44% for year-to-date. Current recommendation for BIOLASE Inc. is 1.70.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. BIOL EPS (TTM) for 12-month is -0.74. EPS for this year is 28.40%, while for the next year its value is -0.24. Its EPS Q/Q reached 17.80%. It has an EPS of 19.20% up for past five years and for the next five years will be up 20.00%.

Let’s take a look on the analyst recommendations on BIOL for the current month and previous month. For the current month, 3 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.65-$3.50. Average target price for BIOL was reached at $2.38.

The insider ownership moved to 27.02% and institutional holding shifted to 23.90%.

The company posted an EPS (TTM) of -0.74. According to the most recent quarter report on (Jun 2020), 2 analysts estimated an average EPS of -0.17, while -0.13 EPS posted a year ago period. Analyst Estimated EPS for BIOL published in the report was -0.2–0.15 during the same period. Comparing with last year, the average estimated EPS was -0.13 which is higher than -0.19 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for BIOL fall -17.29% for period of 200 days. SMA for 50 days was 7.48% which is showing green signal, while SMA-20 was -3.00%. The moving average value for BIOLASE Inc. (BIOL) is 0.5362 and 0.4731 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in BIOL stock. On Jun 09, FEINBERG LARRY N, 10% Owner, sold 1,770,312 trading shares at the cost of $0.55, which valued at 0.98 million. On Jun 08, FEINBERG LARRY N, 10% Owner, sold 3,402,938 shares at the cost of $0.55, with total shares of 264,141. On Feb 11, SCHULER JACK W, 10% Owner, sold 1,307,931 shares at the cost of 0.60. After this transaction, SCHULER JACK W total shares reached to 739,820 which valued at 0.78 million.